The vaccine push continues.
BioNTech, which collaborates with Pfizer is seeking approval fr its vaccine for kids aged 5-11.
According to the report, they are also seeking to apply for approval for kids aged 6 month-2 years old later this year.
— Disclose.tv (@disclosetv) September 10, 2021
BioNTech is set to request approval across the globe to use its COVID-19 vaccine in children as young as five over the next few weeks and preparations for a launch are on track, the biotech firm’s two top executives told Der Spiegel.
“Already over the next few weeks we will file the results of our trial in five to 11 year olds with regulators across the world and will request approval of the vaccine in this age group, also here in Europe,” Chief Medical Officer Oezlem Tuereci told the news weekly.
The confident statements underscore the lead that BioNTech, which collaborates with Pfizer (PFE.N), holds in the race to win broad approval to vaccinate children below the age of 12 in Western countries.
BioNTech has said it expected to file its regulatory dossier on the five to 11 year olds in September. It has also laid out plans to seek approval in children aged 6 months to 2 years later this year.
The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri four years ago at the age of 19. Since its founding, it has gotten over 2M pages views and over 20k followers. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions.